Trend in Antimicrobial Resistance of Staphylococcus aureus: Results from the China Antimicrobial Surveillance Network (CHINET) in the Last 15-Year-Period Reports (2005-2019)

Yingjian Liang; Lidi Qiu; Xiaobin Zheng; Jing Liu

doi:10.2147/IDR.S318005

Trend in Antimicrobial Resistance of Staphylococcus aureus: Results from the China Antimicrobial Surveillance Network (CHINET) in the Last 15-Year-Period Reports (2005-2019)

Infect Drug Resist. 2021 Jun 10:14:2179-2181. doi: 10.2147/IDR.S318005. eCollection 2021.

Authors

Yingjian Liang^#¹, Lidi Qiu^#², Xiaobin Zheng¹, Jing Liu¹

Affiliations

¹ Department of Pulmonary and Critical Care Medicine (PCCM), The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, 519000, People's Republic of China.
² Department of Infectious Disease Intensive Care Unit, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, People's Republic of China.

^# Contributed equally.

Abstract

In this report, we analyze the trends in antimicrobial resistance of Staphylococcus aureus according to the last 15-year-period reports of the China Antimicrobial Surveillance Network (CHINET). It is encouraging that there is a decreasing MRSA proportion in the infection of adults as well as better activity of non-beta-lactam agents in vitro in recent years. However, childhood MRSA infection as well as the tigecycline-resistant MRSA isolate in China deserves increasing concern.

Keywords: China Antimicrobial Surveillance Network; Staphylococcus aureus; antimicrobial resistance.

Publication types

Retracted Publication

Grants and funding

This work was supported by Open project of Key Laboratory of Tropical Disease Control (Sun Yat-sen University), Ministry of Education (grant number 2020kfkt07).